• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates
Home » Critique of internet-based health advice gets serious

Critique of internet-based health advice gets serious

February 10, 2011 By MedCity News

By Chris Seper

WebMD

It’s hard to gauge the impact of The New York Times’ critique of WebMD. Is it just one columnist’s opinion? Or is it a signal that standards for online health advice are going to change?

Times columnist Virginia Heffernan cracked WebMD as “synonymous with Big Pharma Shilling” and the ultimate place for “hypochondria time suck.”

The commercialized nature of WebMD, Heffernan said, can’t hold a candle to the likes of MayoClinic.com, which takes a more straight-forward, calm and clinical approach backed up by the reputation of Mayo itself.

MedCity News logo

Mayo’s storied past as the country’s premier research hospital, in Rochester, Minn., and its storied present as one of Fortune’s ’100 Best Companies to Work For’ surface in the integrity of the site itself, which — though not ad-free — is spare and neatly organized, with the measured, learned voice of the best doctors. The byline for most entries is ’Mayo Clinic staff.’ The integrity of the whole institution is on the line with this site, and the Mayo Clinic has every motivation to keep its information authoritative and up to date.

Mayo’s response to the piece is as staid as Heffernan’s description of its site. “The general consensus at Mayo Clinic regarding the New York Times article from the weekend is that we’re pleased to be recognized for our quality and integrity, and as a credible source for health information online,” Mayo spokeswoman Ginger Polumbo said Monday.

But health systems, which were late dispensing online health information and are now trying to catch up, have to be rubbing their hands. The rule has typically been that content vetted by physicians and other experts meets the standard for top-tier health information (and WebMD follows this rule). And there are so many atrocious health sites offering dangerous and poor medical advice (anorexia, anyone?) that few would think to knock WebMD’s approach.

But Heffernan suggests a higher standard: that advice directly from reputable health systems beats third-party reporting coupled with a review, particularly when there is a greater financial motive behind the latter approach.

News flash: WebMD is a business that wants to make money. Its advertising is clear but can be too subtle. Banner ads are obvious and clearly labeled with small type, though the WebMD-based advertiser pages are easy to mistake for WebMD content.

Heffernan dislikes the amount of pharmaceutical advertising on WebMD and the fact advertising related to the affliction is in and around related content. I think that’s a bogus assertion that runs counter to the online targeting that makes the Web so great (and, as John Sharp points out, this happens at MayoClinic.com as well). Both WebMD and Mayo have fair and transparent advertising policies, though the real issue is how the sites practice what they preach. In look, Mayo has less of a commercial feel.

Though I wonder if that’s all by design. Heffernan underestimates the financial motivation behind any health site run by any institution. Seeking health information is the third most popular activity on the Web behind checking e-mail and using a search engine, according to a new study from Pew Research Center.

Mayo has been making money from its health content by creating personalized portals for private organizations or licensing its health articles to media organizations. In late 2009, it connected with the Everyday Health Network to increase online advertising revenue.

Then there’s the bigger opportunity: using a health site for national and global brand building to attract a number patients who will travel for good healthcare.

MayoClinic.com’s Web traffic enjoyed a surge over the past several years as it jumped ahead of other health information providers. But its numbers and WebMD’s have stabilized, according to the likes of Compete.com and Quantcast. MayoClinic.com has about one-third of WebMD’s traffic, according to those measurement tools.

That flattening of numbers could be due in part to the increase of hospital-made WebMD-like sites, which I believe will be essential for any major health system as part of their marketing efforts.

But amid a glut of health content, good and bad, the idea that direct-for-the-health system content is the best would be a major change. I used to hear people argue the opposite: that there are pluses to having outlets besides hospitals, which have the potential conflict around driving referrals and preference toward certain treatments and research, produce third-party advice (a practice formerly known as journalism).

But increasingly I hear the opinion echoed by the journalist Heffernan. And such a change would mean that health systems, which lost some of its influence for health information before the Internet revolution, would suddenly regain mindshare they lost to the Web and the WebMD’s of the world.

And you can’t put a price on that.

Filed Under: News Well Tagged With: Mayo Clinic

In case you missed it

  • Zimmer Biomet narrowly avoids shareholder rebuke on executive pay
  • FDA says Philips ventilator recall produced over 21,000 device reports, 124 deaths
  • Boston Scientific’s Acurate Neo2 valve performs well in studies
  • MicroTransponder reports first commercial implantation of its stroke rehab neurostim system
  • Ambu replaces CEO with new leadership
  • Moderna’s first bivalent COVID-19 vaccine booster candidate shows promise
  • AdvaMed joins Biden’s Joint Supply Chain Resilience Working Group
  • FDA clears Accelus’ Toro-L interbody fusion system
  • Teleflex’s UroLift cleared in China to treat BPH
  • Globus Medical announces first surgeries with Excelsius3D
  • Abbott reports positive data on heart valve therapies
  • OncoRes Medical raises another $12.5M
  • NeuroMetrix’s Quell neuromodulation device wins FDA de novo nod to treat fibromyalgia
  • Inogen appoints Agnes Lee as senior VP of investor relations, strategic planning
  • Google Health hires FDA’s chief digital health officer
  • ApiJect picks up $111M investment from Royalty Pharma, Jefferies
  • Expect more heart and lung failure years after COVID, Abbott’s heart failure CMO says

RSS From Medical Design & Outsourcing

  • Zimmer Biomet narrowly avoids shareholder rebuke on executive pay
    An unusually large share of Zimmer Biomet (NYSE:ZBH) investors voted against the orthopedics company’s pay packages for top executives at the annual shareholder meeting. About 54% of voting shareholders supported the pay packages of the company’s five top-paid executives at the May 13 meeting, according to results filed with the SEC yesterday. In 2021, nearly 93%… […]
  • BD, Mitsubishi Gas Chemical partner on better materials for plastic syringes
    BD (NYSE:BDX) announced that it partnered with Mitsubishi Gas Chemical Company on applying new technology to pre-fillable syringes. MGC develops the Oxycapt technology designed to integrate the best of plastic and glass for plastic syringes. BD and Tokyo-based MGC will work together to apply Oxycapt technology to the next generation of pre-fillable syringes (PFS) for advanced… […]
  • Ambu replaces CEO with new leadership
    Ambu today said it has hired board member Britt Meelby Jensen to replace CEO Juan Jose Gonzalez, effective tomorrow. “Since Juan Jose Gonzalez joined as CEO in 2019, Ambu has made good progress and achieved important milestones on the strategic transformation into the world’s largest single-use endoscopy company,” Ambu Chair Jørgen Jensen said in a… […]
  • AdvaMed joins Biden’s Joint Supply Chain Resilience Working Group
    AdvaMed executive Abby Pratt has joined the executive committee for the Biden administration’s Joint Supply Chain Resilience Working Group, the medtech industry association said today. The working group’s members from government and industry will assist with implementation of the National Strategy for a Resilient Public Health Supply Chain. Pratt oversees supply chain issues as SVP… […]
  • Toray develops new stretchable film for medical devices
    Toray Industries has a new stretchable film based on its proprietary polymer Reactis technology, with potential applications that include robotics and biological and industrial sensors. Tokyo-based Toray said it shipped samples to customers and plans research and development efforts to commercialize the new grade of film. “Recent years have increased the potential for developing stretchable… […]
  • Google Health hires FDA’s chief digital health officer
    Former FDA Chief Digital Health Officer of Global Strategy and Innovation Bakul Patel has started a new job with Google after 13 years with the regulatory agency. Patel became senior director, global digital health strategy and regulatory for Google Health earlier this month, he said on LinkedIn. Patel recounted highlights of his “incredible journey since… […]
  • Expect more heart and lung failure years after COVID, Abbott’s heart failure CMO says
    Two years into the COVID-19 pandemic, we know more than ever about the SARS-CoV-2 virus and how quickly it moves to ravage the human body. What remains to be seen is how the virus — and perhaps more importantly, our immune system’s response to it — will affect the health of people long after infection,… […]
  • FDA moves forward with Voluntary Improvement Program to bolster medical device quality
    Kathryn Burke, Emergo Group The U.S. Food and Drug Administration has issued new draft guidance to establish a full-blown voluntary program for improving quality-related processes in medical device manufacturing following promising results of a pilot program. The FDA guidance stems from a pilot undertaken by the agency along with the Medical Device Innovation Consortium (MDIC) in 2018.… […]
  • How Minnetronix Medical helped Lazurite with its wireless surgical camera
    Minnetronix Medical (St. Paul, Minnesota) has played an important development and manufacturing partner role with Lazurite’s wireless surgical camera system. It’s been nearly two months since Lazurite (formerly Indago) announced FDA 510(k) clearance of its ArthroFree system. ArthroFree combines proprietary low-heat, high-intensity Meridiem light engine technology with advanced camera, battery and wireless transmission technologies and… […]
  • Instron releases TrendTracker data analysis workflow platform
    Instron announced that it released the TrendTracker module in Bluehill Central for accelerating data analysis workflows. Norwood, Massachusetts-based Instron designed TrendTracker with an intuitive interface to improve the data analysis workflow of single or multi-location materials testing laboratories. According to a news release, the platform features quick searching and the ability to display and analyze… […]
  • Henry Schein hires former Medline veteran to drive ‘One Distribution’ push
    Henry Schein (Nasdaq:HSIC) today named Dirk Benson as VP and chief commercial officer of the medical device manufacturer and distributor’s North America Distribution Group (NADG). Melville, New York-based Henry Schein is the world’s largest provider of health care supplies and services for office-based dental and medical practitioners, and NADG is the company’s largest business group. The… […]

Leave a Reply

You must be logged in to post a comment.

Primary Sidebar

DeviceTalks Weekly

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS